Chemours Valuation

CC Stock  USD 28.88  1.51  5.52%   
At this time, the firm appears to be undervalued. Chemours shows a prevailing Real Value of $31.52 per share. The current price of the firm is $28.88. Our model approximates the value of Chemours from analyzing the firm fundamentals such as profit margin of (0.05) %, and Return On Equity of -0.3 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Price Book
5.3811
Enterprise Value
7.4 B
Enterprise Value Ebitda
39.9987
Price Sales
0.7086
Forward PE
7.148
Undervalued
Today
28.88
Please note that Chemours' price fluctuation is not too volatile at this time. Calculation of the real value of Chemours is based on 3 months time horizon. Increasing Chemours' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Chemours Co is useful when determining the fair value of the Chemours stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Chemours. Since Chemours is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chemours Stock. However, Chemours' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  28.88 Real  31.52 Target  37.89 Hype  28.87 Naive  29.35
The real value of Chemours Stock, also known as its intrinsic value, is the underlying worth of Chemours Company, which is reflected in its stock price. It is based on Chemours' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Chemours' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Chemours' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
31.52
Real Value
36.90
Upside
Estimating the potential upside or downside of Chemours Co helps investors to forecast how Chemours stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chemours more accurately as focusing exclusively on Chemours' fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.710.250.86
Details
Hype
Prediction
LowEstimatedHigh
23.4928.8734.25
Details
Potential
Annual Dividend
LowForecastedHigh
0.580.670.75
Details
10 Analysts
Consensus
LowTarget PriceHigh
34.4837.8942.06
Details

Chemours Investments

2.83 Million

Chemours Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Chemours's current stock value. Our valuation model uses many indicators to compare Chemours value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chemours competition to find correlations between indicators driving Chemours's intrinsic value. More Info.
Chemours Co is rated third in price to earning category among related companies. It is number one stock in price to book category among related companies fabricating about  0.21  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Chemours Co is roughly  4.74 . The current year's Price To Book Ratio is expected to grow to 6.22. Comparative valuation analysis is a catch-all model that can be used if you cannot value Chemours by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Chemours' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chemours' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Chemours' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Chemours and how it compares across the competition.

About Chemours Valuation

The stock valuation mechanism determines the current worth of Chemours Co on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Chemours Co. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Chemours based exclusively on its fundamental and basic technical indicators. By analyzing Chemours's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Chemours's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Chemours. We calculate exposure to Chemours's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Chemours's related companies.
Last ReportedProjected for 2024
Gross Profit1.5 B1.2 B
Pretax Profit Margin 0.13  0.10 
Operating Profit Margin 0.15  0.13 
Net Profit Margin 0.1  0.08 
Gross Profit Margin 0.27  0.26 

8 Steps to conduct Chemours' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Chemours' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Chemours' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Chemours' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Chemours' revenue streams: Identify Chemours' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Chemours' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Chemours' growth potential: Evaluate Chemours' management, business model, and growth potential.
  • Determine Chemours' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Chemours' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.
Chemours' stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Chemours' value is low or high relative to the company's performance and growth projections. Determining the market value of Chemours can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of Chemours represents a small ownership stake in the entity. As a stockholder of Chemours, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

Chemours Dividends Analysis For Valuation

At present, Chemours' Dividend Yield is projected to slightly decrease based on the last few years of reporting. . At present, Chemours' Retained Earnings Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 9.57, whereas Price Earnings Ratio is forecasted to decline to 8.99.
Last ReportedProjected for 2024
Dividends Paid177.1 M128.1 M
Dividend Payout Ratio 0.31  0.32 
Dividend Paid And Capex Coverage Ratio(5.67)(5.95)
Dividend Yield 0.04  0.04 
There are various types of dividends Chemours can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Chemours shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Chemours Co directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Chemours pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Chemours by the value of the dividends paid out.

Chemours Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Chemours does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding158.3 M
Quarterly Earnings Growth Y O Y-0.914
Forward Price Earnings7.148

Chemours Current Valuation Indicators

Valuation refers to the process of determining the present value of Chemours Co and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Chemours we look at many different elements of the entity such as Chemours's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Chemours' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Chemours' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Chemours, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Chemours' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Chemours' worth.
When determining whether Chemours offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chemours' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chemours Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chemours Co Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Chemours Stock analysis

When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.91)
Dividend Share
1
Earnings Share
(2.00)
Revenue Per Share
40.243
Quarterly Revenue Growth
(0.16)
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.